Eric K. Richfield, MD - Publications

Affiliations: 
Rutgers University, New Brunswick, New Brunswick, NJ, United States 

53/76 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Richfield E, Prasad K, Brenneman M, Goraczniak R, Gunderson S. 259. Targeted Gene Silencing by U1 Adaptor Oligonucleotides in Preclinical Models of Parkinson's Disease and Huntington's Disease Molecular Therapy. 24: S102. DOI: 10.1016/S1525-0016(16)33068-4  0.331
2013 Ramos RL, Van Dine SE, George E, Patel D, Hoplight BJ, Leheste JR, Richfield EK, Torres G. Molecular layer heterotopia of the cerebellar vermis in mutant and transgenic mouse models on a C57BL/6 background. Brain Research Bulletin. 97: 63-8. PMID 23735805 DOI: 10.1016/J.Brainresbull.2013.05.001  0.329
2013 Mangaru Z, Salem E, Sherman M, Van Dine SE, Bhambri A, Brumberg JC, Richfield EK, Gabel LA, Ramos RL. Neuronal migration defect of the developing cerebellar vermis in substrains of C57BL/6 mice: cytoarchitecture and prevalence of molecular layer heterotopia. Developmental Neuroscience. 35: 28-39. PMID 23428637 DOI: 10.1159/000346368  0.33
2011 Yin L, Lu L, Prasad K, Richfield EK, Unger EL, Xu J, Jones BC. Genetic-based, differential susceptibility to paraquat neurotoxicity in mice. Neurotoxicology and Teratology. 33: 415-21. PMID 21371552 DOI: 10.1016/J.Ntt.2011.02.012  0.389
2011 Prasad K, Tarasewicz E, Strickland PA, O'Neill M, Mitchell SN, Merchant K, Tep S, Hilton K, Datwani A, Buttini M, Mueller-Steiner S, Richfield EK. Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background. The European Journal of Neuroscience. 33: 642-56. PMID 21272100 DOI: 10.1111/J.1460-9568.2010.07558.X  0.384
2010 Prasad K, Richfield EK. Number and nuclear morphology of TH+ and TH- neurons in the mouse ventral midbrain using epifluorescence stereology. Experimental Neurology. 225: 328-40. PMID 20637754 DOI: 10.1016/J.Expneurol.2010.07.004  0.318
2009 Prasad K, Tarasewicz E, Mathew J, Strickland PA, Buckley B, Richardson JR, Richfield EK. Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brain. Experimental Neurology. 215: 358-67. PMID 19084006 DOI: 10.1016/J.Expneurol.2008.11.003  0.317
2008 Prasad K, Richfield EK. Sporadic midbrain dopamine neuron abnormalities in laboratory mice. Neurobiology of Disease. 32: 262-72. PMID 18687402 DOI: 10.1016/J.Nbd.2008.07.007  0.375
2007 Prasad K, Winnik B, Thiruchelvam MJ, Buckley B, Mirochnitchenko O, Richfield EK. Prolonged toxicokinetics and toxicodynamics of paraquat in mouse brain. Environmental Health Perspectives. 115: 1448-53. PMID 17938734 DOI: 10.1289/Ehp.9932  0.325
2007 Barlow BK, Cory-Slechta DA, Richfield EK, Thiruchelvam M. The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder. Reproductive Toxicology (Elmsford, N.Y.). 23: 457-70. PMID 17350799 DOI: 10.1016/J.Reprotox.2007.01.007  0.371
2006 Chen L, Thiruchelvam MJ, Madura K, Richfield EK. Proteasome dysfunction in aged human alpha-synuclein transgenic mice. Neurobiology of Disease. 23: 120-6. PMID 16713278 DOI: 10.1016/J.Nbd.2006.02.004  0.342
2005 Cory-Slechta DA, Thiruchelvam M, Barlow BK, Richfield EK. Developmental pesticide models of the Parkinson disease phenotype. Environmental Health Perspectives. 113: 1263-70. PMID 16140639 DOI: 10.1289/Ehp.7570  0.417
2005 Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Richfield EK, Buckley B, Mirochnitchenko O. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. The Journal of Biological Chemistry. 280: 22530-9. PMID 15824117 DOI: 10.1074/Jbc.M500417200  0.363
2005 Cory-Slechta DA, Thiruchelvam M, Richfield EK, Barlow BK, Brooks AI. Developmental pesticide exposures and the Parkinson's disease phenotype. Birth Defects Research. Part a, Clinical and Molecular Teratology. 73: 136-9. PMID 15751039 DOI: 10.1002/Bdra.20118  0.412
2004 Barlow BK, Richfield EK, Cory-Slechta DA, Thiruchelvam M. A fetal risk factor for Parkinson's disease. Developmental Neuroscience. 26: 11-23. PMID 15509894 DOI: 10.1159/000080707  0.379
2004 Reeves R, Thiruchelvam M, Richfield EK, Cory-Slechta DA. The effect of developmental exposure to the fungicide triadimefon on behavioral sensitization to triadimefon during adulthood. Toxicology and Applied Pharmacology. 200: 54-63. PMID 15451308 DOI: 10.1016/J.Taap.2004.03.020  0.395
2004 Thiruchelvam MJ, Powers JM, Cory-Slechta DA, Richfield EK. Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice. The European Journal of Neuroscience. 19: 845-54. PMID 15009131 DOI: 10.1111/J.0953-816X.2004.03139.X  0.339
2003 Reeves R, Thiruchelvam M, Richfield EK, Cory-Slechta DA. Behavioral sensitization and long-term neurochemical alterations associated with the fungicide triadimefon. Pharmacology, Biochemistry, and Behavior. 76: 315-26. PMID 14592684 DOI: 10.1016/J.Pbb.2003.08.003  0.405
2003 Thiruchelvam M, McCormack A, Richfield EK, Baggs RB, Tank AW, Di Monte DA, Cory-Slechta DA. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. The European Journal of Neuroscience. 18: 589-600. PMID 12911755 DOI: 10.1046/J.1460-9568.2003.02781.X  0.388
2003 Barlow BK, Thiruchelvam MJ, Bennice L, Cory-Slechta DA, Ballatori N, Richfield EK. Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates. Journal of Neurochemistry. 85: 1075-86. PMID 12716439 DOI: 10.1046/J.1471-4159.2003.01773.X  0.395
2002 Thiruchelvam M, Richfield EK, Goodman BM, Baggs RB, Cory-Slechta DA. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology. 23: 621-33. PMID 12428734 DOI: 10.1016/S0161-813X(02)00092-X  0.379
2002 Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, Di Monte DA, Federoff HJ. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Experimental Neurology. 175: 35-48. PMID 12009758 DOI: 10.1006/Exnr.2002.7882  0.374
2002 Richfield EK, Vonsattel JP, MacDonald ME, Sun Z, Deng YP, Reiner A. Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 327-32. PMID 11921119 DOI: 10.1002/Mds.10032  0.354
2000 Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 9207-14. PMID 11124998 DOI: 10.1523/Jneurosci.20-24-09207.2000  0.419
2000 Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, Cory-Slechta DA. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Research. 873: 225-34. PMID 10930548 DOI: 10.1016/S0006-8993(00)02496-3  0.389
1998 McCoy L, Cox C, Richfield EK. Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression. Synapse (New York, N.Y.). 28: 195-207. PMID 9488504 DOI: 10.1002/(Sici)1098-2396(199803)28:3<195::Aid-Syn2>3.0.Co;2-5  0.352
1997 McCoy L, Richfield EK, Cory-Slechta DA. Regional decreases in alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) and 6-[3H]cyano-7-nitroquinoxaline-2,3-dione ([3H]CNQX) binding in response to chronic low-level lead exposure: reversal versus potentiation by chronic dopamine agonist treatment. Journal of Neurochemistry. 69: 2466-76. PMID 9375679 DOI: 10.1046/J.1471-4159.1997.69062466.X  0.405
1997 Cory-Slechta DA, McCoy L, Richfield EK. Time course and regional basis of Pb-induced changes in MK-801 binding: reversal by chronic treatment with the dopamine agonist apomorphine but not the D1 agonist SKF-82958. Journal of Neurochemistry. 68: 2012-23. PMID 9109527 DOI: 10.1046/J.1471-4159.1997.68052012.X  0.412
1996 McCoy L, Cox C, Richfield EK. Chronic treatment with typical and atypical antipsychotics increases the AMPA-preferring form of AMPA receptor in rat brain. European Journal of Pharmacology. 318: 41-5. PMID 9007511 DOI: 10.1016/S0014-2999(96)00910-7  0.313
1996 Voorn P, Brady LS, Berendse HW, Richfield EK. Densitometrical analysis of opioid receptor ligand binding in the human striatum--I. Distribution of mu opioid receptor defines shell and core of the ventral striatum. Neuroscience. 75: 777-92. PMID 8951872 DOI: 10.1016/0306-4522(96)00271-0  0.365
1996 Vonkeman HE, Voorn P, Brady LS, Berendse HW, Richfield EK. Opioid receptor ligand binding in the human striatum: II. Heterogeneous distribution of kappa opioid receptor labeled with [3H]bremazocine. The Journal of Comparative Neurology. 374: 223-9. PMID 8906495 DOI: 10.1002/(Sici)1096-9861(19961014)374:2<223::Aid-Cne5>3.0.Co;2-4  0.367
1996 Pokora MJ, Richfield EK, Cory-Slechta DA. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments. Journal of Neurochemistry. 67: 1540-50. PMID 8858938 DOI: 10.1046/J.1471-4159.1996.67041540.X  0.412
1996 McCoy L, Richfield EK. Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain. Neuroscience Letters. 213: 137-41. PMID 8858627 DOI: 10.1016/0304-3940(96)12834-2  0.334
1995 Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voorn P. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Annals of Neurology. 38: 852-61. PMID 8526457 DOI: 10.1002/Ana.410380605  0.331
1995 Richfield EK, Maguire-Zeiss KA, Cox C, Gilmore J, Voorn P. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients. Annals of Neurology. 37: 335-43. PMID 7695232 DOI: 10.1002/Ana.410370309  0.339
1995 Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Experimental Neurology. 133: 265-72. PMID 7649231 DOI: 10.1006/Exnr.1995.1029  0.303
1995 Richfield EK, Maguire-Zeiss KA, Vonkemann HE, Voorn P. Preferential Loss Of Preproenkephalin Versus Preprotachykinin Striatal Neurons From HuntingtonʼS Disease Patients: 190 Journal of Neuropathology and Experimental Neurology. 54: 458. DOI: 10.1097/00005072-199505000-00206  0.319
1994 Veenman CL, Albin RL, Richfield EK, Reiner A. Distributions of GABAA, GABAB, and benzodiazepine receptors in the forebrain and midbrain of pigeons. The Journal of Comparative Neurology. 344: 161-89. PMID 8077457 DOI: 10.1002/Cne.903440202  0.326
1994 Richfield EK, Herkenham M. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Annals of Neurology. 36: 577-84. PMID 7944290 DOI: 10.1002/Ana.410360406  0.403
1994 Voorn P, Brady LS, Schotte A, Berendse HW, Richfield EK. Evidence for two neurochemical divisions in the human nucleus accumbens. The European Journal of Neuroscience. 6: 1913-6. PMID 7704301 DOI: 10.1111/J.1460-9568.1994.Tb00582.X  0.384
1993 Berendse HW, Richfield EK. Heterogeneous distribution of dopamine D1 and D2 receptors in the human ventral striatum. Neuroscience Letters. 150: 75-9. PMID 8097026 DOI: 10.1016/0304-3940(93)90112-X  0.357
1992 Inglefield JR, Richfield EK. Preservation of the density of the dopamine uptake complex in aging Fischer 344 rat brain. Neurobiology of Aging. 13: 383-91. PMID 1625767 DOI: 10.1016/0197-4580(92)90112-B  0.343
1992 Van Dort ME, Kilbourn MR, Chakraborty PK, Richfield EK, Gildersleeve DL, Wieland DM. Iodine-125 and fluorine-18 labeled aryl-1,4-dialkylpiperazines: potential radiopharmaceuticals for in vivo study of the dopamine uptake system. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 43: 671-80. PMID 1325425 DOI: 10.1016/0883-2889(92)90039-H  0.35
1991 Herkenham M, Groen BG, Lynn AB, De Costa BR, Richfield EK. Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Research. 552: 301-10. PMID 1913192 DOI: 10.1016/0006-8993(91)90096-E  0.355
1991 Herkenham M, Lynn AB, de Costa BR, Richfield EK. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Research. 547: 267-74. PMID 1909204 DOI: 10.1016/0006-8993(91)90970-7  0.435
1991 Richfield EK, O'Brien CF, Eskin T, Shoulson I. Heterogeneous dopamine receptor changes in early and late Huntington's disease. Neuroscience Letters. 132: 121-6. PMID 1838580 DOI: 10.1016/0304-3940(91)90448-3  0.381
1991 Richfield EK. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics. Brain Research. 540: 1-13. PMID 1829013 DOI: 10.1016/0006-8993(91)90486-F  0.373
1989 Richfield EK, Penney JB, Young AB. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system. Neuroscience. 30: 767-77. PMID 2528080 DOI: 10.1016/0306-4522(89)90168-1  0.356
1989 Richfield EK, Young AB, Penney JB. Comparative distributions of dopamine D-1 and D-2 receptors in the cerebral cortex of rats, cats, and monkeys. The Journal of Comparative Neurology. 286: 409-26. PMID 2506254 DOI: 10.1002/Cne.902860402  0.336
1987 Richfield EK, Young AB, Penney JB. Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. The Journal of Comparative Neurology. 262: 446-63. PMID 2958517 DOI: 10.1002/Cne.902620308  0.38
1987 Richfield EK, Debowey DL, Penney JB, Young AB. Basal ganglia and cerebral cortical distribution of dopamine D1- and D2-receptors in neonatal and adult cat brain. Neuroscience Letters. 73: 203-8. PMID 2951618 DOI: 10.1016/0304-3940(87)90245-X  0.357
1986 Richfield EK, Young AB, Penney JB. Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections. Brain Research. 383: 121-8. PMID 3768686 DOI: 10.1016/0006-8993(86)90013-2  0.394
1984 Jastrow TRd, Richfield EK, Gnegy ME. Quantitative autoradiography of [3H]sulpiride binding sites in rat brain. Neuroscience Letters. 51: 47-53. PMID 6083509 DOI: 10.1016/0304-3940(84)90261-1  0.326
Low-probability matches (unlikely to be authored by this person)
2009 Stumpo DJ, Broxmeyer HE, Ward T, Cooper S, Hangoc G, Chung YJ, Shelley WC, Richfield EK, Ray MK, Yoder MC, Aplan PD, Blackshear PJ. Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood. 114: 2401-10. PMID 19633199 DOI: 10.1182/Blood-2009-04-214619  0.294
2011 Lipoff DM, Bhambri A, Fokas GJ, Sharma S, Gabel LA, Brumberg JC, Richfield EK, Ramos RL. Neocortical molecular layer heterotopia in substrains of C57BL/6 and C57BL/10 mice. Brain Research. 1391: 36-43. PMID 21419110 DOI: 10.1016/J.Brainres.2011.03.026  0.294
2012 Prasad K, Beach TG, Hedreen J, Richfield EK. Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease. Brain Pathology (Zurich, Switzerland). 22: 811-25. PMID 22452578 DOI: 10.1111/J.1750-3639.2012.00597.X  0.287
1995 Kazee AM, Cox C, Richfield EK. Substantia nigra lesions in Alzheimer disease and normal aging. Alzheimer Disease and Associated Disorders. 9: 61-7. PMID 7662324 DOI: 10.1097/00002093-199509020-00001  0.284
2011 Peneder TM, Scholze P, Berger ML, Reither H, Heinze G, Bertl J, Bauer J, Richfield EK, Hornykiewicz O, Pifl C. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice. Neuroscience. 180: 280-92. PMID 21333719 DOI: 10.1016/J.Neuroscience.2011.02.017  0.283
2005 Mhyre TR, Chesler EJ, Thiruchelvam M, Lungu C, Cory-Slechta DA, Fry JD, Richfield EK. Heritability, correlations and in silico mapping of locomotor behavior and neurochemistry in inbred strains of mice. Genes, Brain, and Behavior. 4: 209-28. PMID 15924554 DOI: 10.1111/J.1601-183X.2004.00102.X  0.28
1987 Richfield EK, Twyman R, Berent S. Neurological syndrome following bilateral damage to the head of the caudate nuclei. Annals of Neurology. 22: 768-71. PMID 3435086 DOI: 10.1002/Ana.410220615  0.26
1997 McCoy L, Richfield EK. In-vitro augmentation of NMDA receptor activity by typical and atypical antipsychotic drugs Schizophrenia Research. 24: 79. DOI: 10.1016/S0920-9964(97)82215-3  0.258
2009 Winnik B, Barr DB, Thiruchelvam M, Montesano MA, Richfield EK, Buckley B. Quantification of Paraquat, MPTP, and MPP+ in brain tissue using microwave-assisted solvent extraction (MASE) and high-performance liquid chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry. 395: 195-201. PMID 19618168 DOI: 10.1007/S00216-009-2929-Z  0.257
2005 Dietrich J, Lacagnina M, Gass D, Richfield E, Mayer-Pröschel M, Noble M, Torres C, Pröschel C. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nature Medicine. 11: 277-83. PMID 15723074 DOI: 10.1038/Nm1195  0.252
2002 Detrait ER, Bowers WJ, Halterman MW, Giuliano RE, Bennice L, Federoff HJ, Richfield EK. Reporter gene transfer induces apoptosis in primary cortical neurons. Molecular Therapy : the Journal of the American Society of Gene Therapy. 5: 723-30. PMID 12027556 DOI: 10.1006/Mthe.2002.0609  0.252
2005 Blackshear PJ, Phillips RS, Ghosh S, Ramos SB, Ramos SV, Richfield EK, Lai WS. Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins. Biology of Reproduction. 73: 297-307. PMID 15814898 DOI: 10.1095/Biolreprod.105.040527  0.252
1999 Powers JM, DeCiero D, Cox C, Ito M, Richfield E, Moser A, Moser H. THE DORSAL ROOT GANGLIA IN ADRENOMYELO-NEUROPATHY (AMN) Journal of Neuropathology and Experimental Neurology. 58: 559. DOI: 10.1097/00005072-199905000-00212  0.222
2017 Brown T, Dhillon S, Chung B, Richfield E, Lubitz S. Lymphocytic hypophysitis in the elderly: A case presentation and review of the literature Interdisciplinary Neurosurgery. 8: 43-49. DOI: 10.1016/J.Inat.2016.10.007  0.209
1993 Richfield EK. Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake on the dopamine uptake complex. Molecular Pharmacology. 43: 100-8. PMID 8423763  0.209
2005 Blackshear PJ, Phillips RS, Ghosh S, Ramos SBV, Richfield EK, Lai WS. Erratum: Zfp3613, a rodent X chromosome gene encoding a placenta-specific member of the tristetraprolin family of CCCH tandem zinc finger proteins (Biology of Reproduction (April 6, 2005) 73 (297-307) DOI: 10.1095/biolreprod. 105.040527) Biology of Reproduction. 73. DOI: 10.1095/Biolreprod.105.047555  0.206
1981 Richfield EK, Cohen BA, Albers JW. Review of quantitative and automated needle electromyographic analyses. Ieee Transactions On Bio-Medical Engineering. 28: 506-14. PMID 7275131 DOI: 10.1109/Tbme.1981.324737  0.205
1996 McCoy L, Richfield EK. Washable endogenous substances and regional heterogeneity in agonist enhanced [3H]MK-801 binding in rat brain. Brain Research. 710: 103-11. PMID 8963647 DOI: 10.1016/0006-8993(95)01357-1  0.179
2001 Powers JM, DeCiero DP, Cox C, Richfield EK, Ito M, Moser AB, Moser HW. The dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria. Journal of Neuropathology and Experimental Neurology. 60: 493-501. PMID 11379824  0.17
1992 Schwid S, Ketonen L, Betts R, Richfield E, Kieburtz K. Cerebrovascular complications after primary varicella-zoster infection The Lancet. 340: 669. PMID 1355225 DOI: 10.1016/0140-6736(92)92199-P  0.167
2010 Nicholas A, de Magalhaes JP, Kraytsberg Y, Richfield EK, Levanon EY, Khrapko K. Age-related gene-specific changes of A-to-I mRNA editing in the human brain. Mechanisms of Ageing and Development. 131: 445-7. PMID 20538013 DOI: 10.1016/j.mad.2010.06.001  0.134
1988 Richfield EK, Ciliax BJ, Starosta-Rubinstein SR, McKeever PE, Penney JB, Young AB. Comparison of [14C]-deoxyglucose metabolism and peripheral benzodiazepine receptor binding in rat C6 glioma. Neurology. 38: 1255-62. PMID 2840604 DOI: 10.1212/Wnl.38.8.1255  0.126
2003 Abdelhalim AN, Moritani T, Richfield E, Ekholm SE, Westesson PL. Epidermal nevus syndrome: megalencephaly with bihemispheric and cerebellar involvement: imaging and neuropathologic correlation. Journal of Computer Assisted Tomography. 27: 534-7. PMID 12886138 DOI: 10.1097/00004728-200307000-00014  0.113
Hide low-probability matches.